The W.M. Keck Foundation is a private foundation, established in 1954 by William Myron Keck, founder of the Superior Oil Company, and based in Los Angeles. Alongside a separate Undergraduate Education Program and a Southern California Grant Program, its Research Program is one of the more closely watched sources of private, non-federal funding for early-stage, high-risk basic research at U.S. universities and independent research institutes — a niche many applicants turn to specifically because it will fund work that a federal study section might consider too speculative to score well.
What the Keck Foundation Research Program funds
The Research Program is organized around a single, explicit criterion: it wants to fund work that is distinctive and novel in its approach, that challenges the prevailing paradigm, or that has the potential to break open new territory in a field. The Foundation is explicit that it is looking for high-risk, early-stage projects — ones that would struggle to compete for conventional peer-reviewed funding precisely because they are too novel, too far from an established research program’s proven track record, or too likely to fail outright. Many successful Keck applications explicitly document that the proposed work was already declined by NIH, NSF, or another conventional funder on exactly those grounds, and applicants are generally expected to be able to point to that kind of feedback as evidence the project is genuinely high-risk rather than merely underfunded.
That single criterion is applied across two programmatic areas:
Science and Engineering Research
Covers physical sciences, life sciences, and engineering. The Foundation looks for proposals built around a clearly identified fundamental scientific question, often involving new instrumentation or a novel combination of validated and emerging methods, rather than an incremental extension of an existing research program. Applied engineering aimed narrowly at improving efficiency or reducing cost of an existing process or product is not a fit.
Medical Research
Covers basic biomedical science. The Foundation is explicit that it does not fund disease-specific projects, translational or bench-to-bedside research, clinical trials, drug discovery or delivery, medical devices, or biomarker/diagnostic screening work — the Medical Research area is scoped to fundamental biological questions, not applied or clinical medicine. Institutions and reviewers preparing a Keck submission should read this exclusion carefully, since it is one of the most common reasons a technically strong proposal is a poor fit for this particular program.
Across both areas, the Foundation also does not fund conferences, symposia, budget supplements to already-funded work, or continuation/follow-on funding for a previously completed Keck grant.
Eligibility
Applicant organizations must be accredited, U.S.-based, tax-exempt institutions under Section 501(c)(3) of the Internal Revenue Code — in practice, primarily PhD-granting research universities and independent nonprofit research institutes. As with most major private foundations, individual researchers cannot apply directly; the application is submitted institutionally, typically through the sponsored-programs or foundation-relations office, with the principal investigator developing the scientific content. Because eligibility and program guidelines are periodically revised, an institution should always confirm current requirements directly against the Foundation’s own published guidelines at wmkeck.org before beginning a submission, rather than relying on a prior year’s cycle.
Institutional limits and internal competition
The Keck Foundation caps how many applications it will accept from a single institution per cycle, which means most research universities run their own internal limited-submission competition before anything goes to the Foundation at all — faculty submit an internal concept or pre-proposal to the sponsored-programs or foundation-relations office, which selects the strongest one or two candidates (typically split across the Science and Engineering and Medical Research areas) to actually go forward. A research administrator supporting Keck applicants should build institutional deadlines several weeks ahead of the Foundation’s own dates specifically to leave room for this internal selection step, and should expect it to be genuinely competitive at a research-intensive institution, where several strong concepts are often competing for a single institutional slot.
The application process: staged review, not a single submission
Keck’s Research Program does not use a single-stage application. Instead, it runs a staged model that starts narrow and only asks for full technical detail once a project has cleared earlier gates — the same logic behind a letter-of-inquiry (LOI) process used by many private foundations, designed to let a program officer screen fit and novelty before either side invests in a lengthy full proposal. The exact mechanics of Keck’s process have been revised more than once in recent cycles (including changes to whether a separate concept-counseling step is offered ahead of the formal stages), so the description below covers the structure applicants should expect rather than a fixed set of dates:
- Concept stage. Institutions typically begin with a brief concept description, submitted through the Foundation’s online portal, that lays out the fundamental question and why it is high-risk and paradigm-challenging. This is the stage an institution’s internal limited-submission review usually mirrors before anything reaches the Foundation.
- Phase I proposal. Concepts the Foundation wants to see developed further are invited to submit a short Phase I proposal — a few pages describing the scientific question, approach, and why conventional funders have not supported it.
- Phase II proposal. A subset of Phase I submissions are invited to submit a longer, fully developed Phase II proposal, including a detailed budget and often followed by a scientific presentation or interview before a final funding decision.
The Foundation runs two cycles per year (roughly a spring/summer cycle and a fall/winter cycle), each with its own sequence of deadlines for each stage above. Because those specific dates change from cycle to cycle and the Foundation has adjusted the process itself in recent years, treat any date found in a search result or a prior year’s institutional guidance as provisional and verify the live deadline on the Foundation’s own site, or through your institution’s sponsored-programs office, before building a submission timeline around it.
Award size and duration
Keck Research Program grants are generally awarded in the range of roughly $1 million to $1.3 million over about three years — sizable relative to a typical federal R01-level award, and structured as a lump sum rather than incrementally funded year over year. As with most private foundations, the Foundation does not reimburse indirect costs (F&A) the way a federal sponsor does; institutions should confirm the Foundation’s current indirect-cost policy directly, since private-foundation F&A treatment varies and is a common point of internal budget friction between a PI and their sponsored-programs office.
How Keck funding compares to federal grant mechanisms
For a research administrator more used to a foundation grant being a smaller, faster-turnaround award than a federal one, Keck is an instructive exception: it funds at a scale and duration comparable to a major federal award, but through a fundamentally different review logic. A federal competitive grant like an NIH R01 is peer-reviewed against a detailed set of scored criteria including rigor, feasibility, and preliminary data — exactly the track record Keck is not primarily looking for. Keck’s staged LOI-style model, by contrast, is built to surface projects that would score poorly on “feasibility based on preliminary data” precisely because they are new enough that no preliminary data yet exists. This is also why so much Keck guidance explicitly recommends first attempting (and being declined by) a conventional funder: it is treated as evidence the project belongs in Keck’s high-risk niche rather than in the federal pipeline. See CASRAI’s Grants Management & Research Funding hub for how this fits into the broader pre-award workflow, and the NIH RFA guide for a contrasting federal, set-aside-funded process.
Frequently asked questions
Does the W.M. Keck Foundation accept applications directly from individual researchers?
No. Like most major private research foundations, Keck requires applications to come through an eligible institution — an accredited, U.S.-based, 501(c)(3) tax-exempt organization — with the institution’s sponsored-programs or foundation-relations office typically managing submission on behalf of the principal investigator.
What is the difference between the Science and Engineering Research and Medical Research areas?
Both apply the same underlying criterion — distinctive, paradigm-challenging, high-risk basic research — but to different subject matter. Science and Engineering Research covers physical sciences, life sciences, and engineering; Medical Research is scoped specifically to fundamental biomedical science and explicitly excludes disease-specific, translational, clinical, or drug-development work.
Can an institution submit more than one Keck Research Program application per cycle?
The Foundation limits how many applications it will accept from a single institution per cycle, which is why most research-intensive universities run an internal limited-submission competition to select their strongest candidate concept(s) before anything is submitted to the Foundation.
Does a Keck Research Program grant cover indirect costs?
Private foundations generally treat indirect costs (F&A) differently than federal sponsors do, and specific policy can change between cycles — confirm the Foundation’s current indirect-cost treatment directly rather than assuming federal-style recovery applies.
What should a project demonstrate to be a good fit for Keck funding?
That it is genuinely high-risk and early-stage — often evidenced by having already been declined by a conventional funder such as NIH or NSF on the grounds that it was too novel or lacked sufficient preliminary data — and that it addresses a clearly identified fundamental question capable of shifting the paradigm in its field, rather than incrementally extending an existing, already-funded line of work.
